Showing results (141-150 of 150) with videos related to
Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 150 results.
Cancer Research|December 7, 2007
Neuroblastoma cells isolated from bone marrow metastases contain a naturally enriched tumor-initiating cellLoen M Hansford, Amy E McKee, Libo Zhang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2016
FDA Approval of Palbociclib in Combination with Fulvestrant for the Treatment of Hormone Receptor-Positive, HER2-Negative Metastatic Breast CancerAmanda J Walker, Suparna Wedam, Laleh Amiri-Kordestani, et al.Microbial Cell Factories|June 15, 2012
Manipulation of the carbon storage regulator system for metabolite remodeling and biofuel production in Escherichia coliAdrienne E McKee, Becky J Rutherford, Dylan C Chivian, et al.Journal of Parkinson'S Disease|February 20, 2025
Effects of 6 months of endurance exercise on motor function, exercise capacity, and autonomic function based on presence of autonomic dysfunction in individuals with early Parkinson's diseaseGarett J Griffith, Niyati Mehta, Guillaume Lamotte, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 19, 2015
FDA Approval Summary: Olaparib Monotherapy in Patients with Deleterious Germline BRCA-Mutated Advanced Ovarian Cancer Treated with Three or More Lines of ChemotherapyGeoffrey Kim, Gwynn Ison, Amy E McKee, et al.Journal of the National Comprehensive Cancer Network : JNCCN|November 2, 2014
NCCN Working Group report: designing clinical trials in the era of multiple biomarkers and targeted therapiesAlan P Venook, Maria E Arcila, Al B Benson, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2016
FDA Approval: Uridine Triacetate for the Treatment of Patients Following Fluorouracil or Capecitabine Overdose or Exhibiting Early-Onset Severe Toxicities Following Administration of These DrugsGwynn Ison, Julia A Beaver, W David McGuinn, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2014
FDA approval summary: vemurafenib for treatment of unresectable or metastatic melanoma with the BRAFV600E mutationGeoffrey Kim, Amy E McKee, Yang-Min Ning, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2016
U.S. Food and Drug Administration Approval: Cabozantinib for the Treatment of Advanced Renal Cell CarcinomaHarpreet Singh, Michael Brave, Julia A Beaver, et al.Trials|October 6, 2022
Study in Parkinson's disease of exercise phase 3 (SPARX3): study protocol for a randomized controlled trialCharity G Patterson, Elizabeth Joslin, Alexandra B Gil, et al.Pageof 15